You are currently viewing Evaluation of parasitic cause of Eosinophilia in children in pediatric department of Dhulikhel Hospital and its affiliated health facilities

Evaluation of parasitic cause of Eosinophilia in children in pediatric department of Dhulikhel Hospital and its affiliated health facilities

Project Summary

When our body produces an abnormally high number of eosinophils, it results in eosinophilia. One type of white blood cell that helps in the immune system is eosinophilia. Eosinophilia is a hematologic marker that warrants attention and serves as a clue to help direct a diagnostic workup. Eosinophilia develops as an immunologically mediated response in association with diverse processes, including allergic, neoplastic, and infectious diseases. Although many diseases are associated with eosinophilia, the presence of eosinophilia in a person with tropical exposure suggests the possibility of specific parasitic infections. Eosinophilia is notably common in association with multicellular, helminthic parasites, especially those in tissues.

Eosinophilia in parasitic infections in the result of dynamic interactions that are influenced by host factors, the stage of parasite development, the location of the parasite within the human host, and the parasite burden among other factors. In this study, we are going to conduct a case-control study. This type of study entails choosing an experimental group of patients identified by a particular outcome, such as acquiring a disease, and matching them, patient for the patient, with a control group that does not have this factor. Although control is maintained over the selection of cases, it does not extend to the acquisition of data within these cases.

Study Duration

Dec 2023 – Oct 2025

Objectives

To assess the parasitic cause of eosinophilia in children in the Pediatric Department of Dhulikhel Hospital and its affiliated health facilities.

Outcomes

We expect to successfully identify the cause of eosinophilia in the study participants. This will enable improved treatment of children with eosinophilia as a more appropriate medication may be selected. Depending on the identified cause education may be given to the patient to avoid further contamination and/or reinfection.

Team Members

Co-Principal Investigator(s): Dr. Santosh Gautam, Prof. Dr. Stephan Gehring

Co-Investigator(s): Prof. Dr. Rajeev Shrestha, Dr. Dipesh Tamrakar, Dr. Christian Jensen, Dr. Rajana Karki, Dr. Anish Joshi, Surendra Kumar Madhup, Nishan Katuwal, Sabin Bikram Shahi

Project Coordinator(s): Melina Thapa

Research Assistant(s): N/A

Supported by: Children’s Hospital, Johannes Gutenberg-University, Mainz, Germany

Collaborating Partners: Children’s Hospital, Johannes Gutenberg University, Mainz, Germany

Publications

Not Yet Published